Bio Integrates Focuses on the biotech, start-up and emerging pharma sector addressing the needs of innovative companies that develop therapies of tomorrow.
MedTech Integrates Addresses the needs of the MedTech community to overcome the challenges needed to achieve a transformation of diagnostics and devices in healthcare.
PharmaTech Integrates will bring together all the parties to promote, educate and connect the sector to enhance technology adoption in the responsive manufacture of medicines both new and old.
Facilitating the translation of cutting-edge research and disruptive innovation into the adoption of Advanced Therapies, delivering improved patient outcomes and a revolution in healthcare economics.
Bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
I have participated in several Pharma Integrates and more recently Bio Integrates conferences, both in my capacity as representing a specialist healthcare company and medical research charity. I have always been impressed by the high-profile speakers, the candour with which they shared their experiences, and the professionalism of the conference organisation. This year’s conferences will provide the ideal opportunity to learn about the latest advance in healthcare and to connect and engage with many senior industry colleagues.
Valued sponsors and partners
“WE BRING LEADERS TOGETHER, TO DISCUSS, DEBATE AND UNCOVER STRATEGIC SOLUTIONS TO THEIR INDUSTRY CHALLENGES”
CatSci Ltd, a scientifically-led, commercially-minded and award-winning innovation partner for medicines development was proud to host Vaughan Gething MS, Welsh Minister of Economy, at its facility in Cardiff to open a new material science laboratory.
Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases based on the natural body protein CDNF (Cerebral Dopamine Neurotrophic Factor), today announced that results from the Nanoform Proof of Concept (PoC) project show that the nanoforming process has been successfully applied to Herantis’ rhCDNF drug candidate.
SK pharmteco Inc (SKPT) is pleased to announce that Joyce Fitzharris, currently serving as General Manager, SK Biotek Ireland has been promoted to the office of President, SK biotek Ireland.
